Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Total Costs & Expenses

$7.75B

TTM · Period ending: Jun 30, 2026 · USD

VRTX Total Costs & Expenses

Latest reported$7.75Bperiod endingJun 30, 2026

Latest reported$7.75Bperiod endingJun 30, 2026

VRTX TTM Total Costs & Expenses (-$6.40M → $7.75B)

TTM Total Costs & Expenses

High-resolution chart · PNG

VRTX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	136,486,000
Mar 31, 2001	125,177,000
Dec 31, 2000	116,809,000
Sep 30, 2000	110,204,000
Jun 30, 2000	104,666,000
Mar 31, 2000	102,784,000
Dec 31, 1999	101,100,000
Sep 30, 1999	97,600,000
Jun 30, 1999	94,600,000
Mar 31, 1999	85,700,000
Dec 31, 1998	76,800,000
Sep 30, 1998	70,500,000
Jun 30, 1998	69,200,000
Mar 31, 1998	65,800,000
Dec 31, 1997	62,800,000
Sep 30, 1997	55,400,000
Jun 30, 1997	46,500,000
Mar 31, 1997	44,500,000
Dec 31, 1996	43,100,000
Sep 30, 1996	43,300,000
Jun 30, 1996	43,300,000
Mar 31, 1996	48,700,000
Dec 31, 1995	48,600,000
Sep 30, 1995	49,200,000
Jun 30, 1995	49,200,000
Mar 31, 1995	42,600,000
Dec 31, 1994	40,400,000
Sep 30, 1994	38,700,000
Jun 30, 1994	35,700,000
Mar 31, 1994	31,100,000
Dec 31, 1993	26,700,000
Sep 30, 1993	21,200,000
Jun 30, 1993	17,500,000
Mar 31, 1993	15,200,000
Dec 31, 1992	13,800,000
Sep 30, 1992	12,400,000
Jun 30, 1992	11,000,000
Mar 31, 1992	9,800,000
Dec 31, 1991	6,800,000
Sep 30, 1991	-2,100,000
Jun 30, 1991	-4,300,000
Mar 31, 1991	-6,400,000
Dec 31, 1990	-6,400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.